top of page

Ketones to the Rescue? Rethinking Schizophrenia Treatment with BHB

beta-hydroxybutyrate .jpg

Schizophrenia is a complex brain disorder that affects how a person thinks, feels, and behaves. One of the key issues in schizophrenia is that the brain struggles to use glucose—the main source of energy—effectively. This study explored whether β-hydroxybutyrate (BHB), a compound naturally produced during a ketogenic (low-carb, high-fat) diet, could help improve brain function in this context.

Researchers used a mouse model of schizophrenia-like behavior triggered by a drug called MK-801, which temporarily blocks certain brain receptors. They found that both short-term (acute) and long-term (chronic) treatment with BHB reduced these schizophrenia-like symptoms. Specifically, BHB improved the mice's social behaviors, reduced hyperactivity, and restored normal brain responses to sound—key features often disrupted in schizophrenia.

These findings suggest that BHB might offer a new therapeutic approach for schizophrenia, by giving the brain an alternative energy source when glucose use is impaired—without requiring a strict ketogenic diet.

Want to know more?
👉 Click below to read the full paper.

Want to be informed of future projects?

 

 

If you wish to have your email removed from our mailing list, you can request this at any time by contacting ann-katrin.kraeuter@northumbria.ac.uk. Email addresses will only be used to share information about future study opportunities and recently published research.

© 2035 by BrainBioMet. Powered and secured by Wix 

bottom of page